Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Sudeep Shivakumar"'
Publikováno v:
Current Oncology, Vol 29, Iss 9, Pp 6419-6432 (2022)
Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated with significant morbidity and mortality. The cornerstone of cancer-associated venous thromboembolism treatment is anticoagulation, and in recent years
Externí odkaz:
https://doaj.org/article/773eca9aa66a4a0ba6370ee75ef33fd5
Autor:
Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu, Agnes Y. Y. Lee
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5434-5451 (2021)
Patients with cancer-associated thrombosis (CAT) are at high risk of recurrent venous thromboembolism (VTE) and major bleeding complications. Risks vary significantly between individuals based on cancer status, treatment, and other characteristics. T
Externí odkaz:
https://doaj.org/article/f8bf6815f81f4b45a5ac232a09ac3b2b
Autor:
Kimberly Legault, Mark Blostein, Marc Carrier, Susan Khan, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther
Publikováno v:
Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-7 (2020)
Abstract Background There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and
Externí odkaz:
https://doaj.org/article/8e75d6afce2846d8b7d6c62a71986b26
Autor:
Susan R. Kahn, Sudeep Shivakumar
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 3, Pp 366-376 (2020)
Abstract A State of the Art lecture titled “What’s New in VTE Risk and Prevention in Orthopedic Surgery” was presented at the ISTH congress in 2019. Patients undergoing orthopedic surgery have long been recognized to be at increased risk of ven
Externí odkaz:
https://doaj.org/article/ca6b50f2d789413380675403c647e014
Autor:
Grégoire Le Gal, Sam Schulman, Jean Philippe Galanaud, Jameel Abdulrehman, A Lazo-Langner, Sudeep Shivakumar, Susan Kahn
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Introduction After deep vein thrombosis, up to 50% of patients develop post-thrombotic syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL). Cornerstones of PTS treatment include the use of elastic compression stockings but t
Externí odkaz:
https://doaj.org/article/595a1abe977b482ca2710171a089fd75
Autor:
Kimberly Legault, Mark Blostein, Marc Carrier, Susan Kahn, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther
Publikováno v:
Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/3552391ecb9448fdbe8b3d4f2586d458
Autor:
Na Li, Syed Mahamad, Sameer Parpia, Alfonso Iorio, Farid Foroutan, Nancy M. Heddle, Cyrus C. Hsia, Michelle Sholzberg, Emily Rimmer, Sudeep Shivakumar, Haowei (Linda) Sun, Mohammad Refaei, Caroline Hamm, Donald M. Arnold
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2988-2997
Immune thrombocytopenia (ITP) is a diagnosis of exclusion that can resemble other thrombocytopenic disorders.To develop a clinical prediction model (CPM) for the diagnosis of ITP to aid hematogists in investigating patients presenting with undifferen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e9e0db5152db0f95a25ee701db2a12
https://doi.org/10.1111/jth.15885
https://doi.org/10.1111/jth.15885
Autor:
Nicola Potere, Marcello Di Nisio, Ettore Porreca, Tzu-Fei Wang, Vicky Tagalakis, Sudeep Shivakumar, Aurélien Delluc, Ranjeeta Mallick, Phil S. Wells, Marc Carrier
Publikováno v:
Thrombosis research, 226, 82-85. Elsevier Limited
Background: The use of direct oral anticoagulants (DOACs) in obese patients is uncertain. It is unclear if body mass index (BMI) affects the safety and efficacy of DOACs for the primary prevention of venous thromboembolism (VTE) in high-risk ambulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9728e2c93ea5931c6a87e123d5f3915
https://pure.amc.nl/en/publications/apixaban-thromboprophylaxis-in-ambulatory-patients-with-cancer-and-obesity(38be161d-5651-4892-9b1e-611b17fe1dde).html
https://pure.amc.nl/en/publications/apixaban-thromboprophylaxis-in-ambulatory-patients-with-cancer-and-obesity(38be161d-5651-4892-9b1e-611b17fe1dde).html
Autor:
Michelle Pradier, Marc A. Rodger, Waleed Ghanima, Michael J. Kovacs, Sudeep Shivakumar, Susan R. Kahn, Per Morten Sandset, Clive Kearon, Ranjeeta Mallick, Aurélien Delluc
Publikováno v:
Thrombosis and Haemostasis.
Objective The SOX-PTS, Amin, and Méan models are three different clinical prediction scores stratifying the risk for postthrombotic syndrome (PTS) development in patients with acute deep vein thrombosis (DVT) of the lower limbs. Herein, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50eda4119a38d8e9f27745f41c368d98
https://doi.org/10.1055/a-2039-3388
https://doi.org/10.1055/a-2039-3388
Autor:
Jesse Popov, Suellen Coelho, Marc Carrier, Catherine Sperlich, Susan Solymoss, Nathalie Routhier, Sudeep Shivakumar, Wusiman Aibibula, Susan R. Kahn, Vicky Tagalakis
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 20(8)
Patients with cancer-associated thrombosis (CAT) are treated with full-dose anticoagulation for at least 3 months, but optimal dosing thereafter is unknown.We explored the feasibility of extended prophylactic-dose low molecular weight heparin (LMWH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21340fcff309b80961d26a194de67c5e
https://pubmed.ncbi.nlm.nih.gov/35587536
https://pubmed.ncbi.nlm.nih.gov/35587536